Risk of Paradoxical Rheumatoid Arthritis in Inflammatory Bowel Disease Patients Exposed to Tumor Necrosis Factor Inhibitors: A Propensity-Matched Multicenter Study

Inflamm Bowel Dis. 2024 Sep 11:izae203. doi: 10.1093/ibd/izae203. Online ahead of print.
No abstract available

Keywords: inflammatory bowel disease; rheumatoid arthritis; tumor necrosis factor inhibitors.

Plain language summary

Tumor necrosis factor (TNF) inhibitor therapy for inflammatory bowel disease (IBD) has been associated with an increased risk of rheumatoid arthritis and other inflammatory conditions. Our retrospective study did not show an increased risk when compared with non-anti-TNF therapy for IBD.